• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病相关基因敲入小鼠表现出 tau 神经病理学和多巴胺能神经退行性变。

Parkinson's disease-linked knockin mice manifest tau neuropathology and dopaminergic neurodegeneration.

机构信息

Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI 49503.

Department of Translational Science and Molecular Medicine, Michigan State University, Grand Rapids, MI 49503.

出版信息

Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5765-5774. doi: 10.1073/pnas.1814909116. Epub 2019 Mar 6.

DOI:10.1073/pnas.1814909116
PMID:30842285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6431187/
Abstract

Mutations in the () gene represent a cause of late-onset, autosomal dominant familial Parkinson's disease (PD). A single missense mutation, D620N, is considered pathogenic based upon its segregation with disease in multiple families with PD. At present, the mechanism(s) by which familial mutations precipitate neurodegeneration in PD are poorly understood. Here, we employ a germline knockin (KI) mouse model of PD to formally establish the age-related pathogenic effects of the D620N mutation at physiological expression levels. Our data demonstrate that a heterozygous or homozygous D620N mutation is sufficient to reproduce key neuropathological hallmarks of PD as indicated by the progressive degeneration of nigrostriatal pathway dopaminergic neurons and widespread axonal pathology. Unexpectedly, endogenous D620N VPS35 expression induces robust tau-positive somatodendritic pathology throughout the brain as indicated by abnormal hyperphosphorylated and conformation-specific tau, which may represent an important and early feature of mutant VPS35-induced neurodegeneration in PD. In contrast, we find no evidence for α-synuclein-positive neuropathology in aged KI mice, a hallmark of Lewy body pathology in PD. D620N VPS35 expression also fails to modify the lethal neurodegenerative phenotype of human A53T-α-synuclein transgenic mice. Finally, by crossing KI and null mice, our data demonstrate that a single allele is sufficient for survival and early maintenance of dopaminergic neurons, indicating that the D620N VPS35 protein is fully functional. Our data raise the tantalizing possibility of a pathogenic interplay between mutant VPS35 and tau for inducing neurodegeneration in PD.

摘要

()基因突变是导致迟发性、常染色体显性家族性帕金森病(PD)的一个原因。单一错义突变 D620N 被认为是致病的,因为它在多个 PD 家族中与疾病共分离。目前,家族性突变如何导致 PD 中的神经退行性变的机制尚不清楚。在这里,我们使用 PD 的种系敲入(KI)小鼠模型来正式建立 D620N 突变在生理表达水平下与年龄相关的致病效应。我们的数据表明,杂合或纯合 D620N 突变足以复制 PD 的关键神经病理学特征,如黑质纹状体通路多巴胺能神经元的进行性退化和广泛的轴突病理学。出乎意料的是,内源性 D620N VPS35 表达会诱导整个大脑中强壮的 tau 阳性体树突病理学,如异常高磷酸化和构象特异性 tau 所表明的,这可能代表突变 VPS35 诱导 PD 神经退行性变的一个重要和早期特征。相比之下,我们在老年 KI 小鼠中没有发现α-突触核蛋白阳性神经病理学的证据,这是 PD 路易体病理学的一个标志。D620N VPS35 表达也不能改变人类 A53T-α-突触核蛋白转基因小鼠的致命神经退行性表型。最后,通过交叉 KI 和 null 小鼠,我们的数据表明,单个 等位基因足以维持多巴胺能神经元的存活和早期维持,表明 D620N VPS35 蛋白是完全功能的。我们的数据提出了一个诱人的可能性,即突变 VPS35 和 tau 之间存在致病相互作用,可能导致 PD 中的神经退行性变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/6e53f786a0b0/pnas.1814909116fig09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/0abf006d9a5f/pnas.1814909116fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/188896b7caa7/pnas.1814909116fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/bea2fe274042/pnas.1814909116fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/bf5452a9b7e6/pnas.1814909116fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/7b10ac55e80a/pnas.1814909116fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/6db1d1eba8c8/pnas.1814909116fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/548149488062/pnas.1814909116fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/8fc766876629/pnas.1814909116fig08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/6e53f786a0b0/pnas.1814909116fig09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/0abf006d9a5f/pnas.1814909116fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/188896b7caa7/pnas.1814909116fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/bea2fe274042/pnas.1814909116fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/bf5452a9b7e6/pnas.1814909116fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/7b10ac55e80a/pnas.1814909116fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/6db1d1eba8c8/pnas.1814909116fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/548149488062/pnas.1814909116fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/8fc766876629/pnas.1814909116fig08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46d5/6431187/6e53f786a0b0/pnas.1814909116fig09.jpg

相似文献

1
Parkinson's disease-linked knockin mice manifest tau neuropathology and dopaminergic neurodegeneration.帕金森病相关基因敲入小鼠表现出 tau 神经病理学和多巴胺能神经退行性变。
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5765-5774. doi: 10.1073/pnas.1814909116. Epub 2019 Mar 6.
2
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.VPS35 和 α-突触核蛋白未能相互作用以调节帕金森病啮齿动物模型中的神经退行性变。
Mol Neurodegener. 2023 Aug 4;18(1):51. doi: 10.1186/s13024-023-00641-4.
3
VPS35 D620N knockin mice recapitulate cardinal features of Parkinson's disease.VPS35 D620N 敲入小鼠重现帕金森病的主要特征。
Aging Cell. 2021 May;20(5):e13347. doi: 10.1111/acel.13347. Epub 2021 Mar 21.
4
Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.VPS35中与帕金森病相关的突变会诱发多巴胺能神经变性。
Hum Mol Genet. 2014 Sep 1;23(17):4621-38. doi: 10.1093/hmg/ddu178. Epub 2014 Apr 15.
5
Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.内体运输和谷氨酸突触活性在 VPS35 D620N 突变敲入小鼠神经元中增加,并能抵抗 LRRK2 激酶抑制。
Mol Brain. 2021 Sep 16;14(1):143. doi: 10.1186/s13041-021-00848-w.
6
VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.多巴胺神经元中的VPS35是伴侣介导自噬受体Lamp2a从内体到高尔基体回收所必需的,Lamp2a对α-突触核蛋白降解及预防帕金森病发病机制至关重要。
J Neurosci. 2015 Jul 22;35(29):10613-28. doi: 10.1523/JNEUROSCI.0042-15.2015.
7
(D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.(D620N) VPS35 在 PARK17 基因敲入小鼠模型中导致 Wnt/β-连环蛋白信号级联和线粒体功能障碍。
Cell Death Dis. 2020 Nov 30;11(11):1018. doi: 10.1038/s41419-020-03228-9.
8
Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.帕金森病 VPS35 突变体小鼠模型中海马神经发生受损是通过与 APP 相互作用实现的。
Neurobiol Dis. 2021 Jun;153:105313. doi: 10.1016/j.nbd.2021.105313. Epub 2021 Feb 24.
9
VPS35 and retromer dysfunction in Parkinson's disease.VPS35 和 retromer 功能障碍与帕金森病。
Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220384. doi: 10.1098/rstb.2022.0384. Epub 2024 Feb 19.
10
Role of the VPS35 D620N mutation in Parkinson's disease.VPS35 D620N突变在帕金森病中的作用。
Parkinsonism Relat Disord. 2017 Mar;36:10-18. doi: 10.1016/j.parkreldis.2016.12.001. Epub 2016 Dec 5.

引用本文的文献

1
Emergent glutamate & dopamine dysfunction in VPS35 knock-in mice and rapid reversal by LRRK2 inhibition.VPS35基因敲入小鼠中出现的谷氨酸和多巴胺功能障碍以及LRRK2抑制作用的快速逆转
NPJ Parkinsons Dis. 2025 May 3;11(1):106. doi: 10.1038/s41531-025-00948-7.
2
VPS35-Retromer: Multifunctional Roles in Various Biological Processes - A Focus on Neurodegenerative Diseases and Cancer.VPS35-逆转录复合物:在多种生物学过程中的多功能作用——聚焦神经退行性疾病和癌症
J Inflamm Res. 2025 Apr 3;18:4665-4680. doi: 10.2147/JIR.S510768. eCollection 2025.
3
Immune cell metabolic dysfunction in Parkinson's disease.

本文引用的文献

1
Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice.Vps35 p.D620N基因敲入小鼠中多巴胺释放和单胺转运体的改变
NPJ Parkinsons Dis. 2018 Aug 21;4:27. doi: 10.1038/s41531-018-0063-3. eCollection 2018.
2
Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting.帕金介导 VPS35 的泛素化并调节依赖于逆行小体的内体分选。
Hum Mol Genet. 2018 Sep 15;27(18):3189-3205. doi: 10.1093/hmg/ddy224.
3
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
帕金森病中的免疫细胞代谢功能障碍
Mol Neurodegener. 2025 Mar 24;20(1):36. doi: 10.1186/s13024-025-00827-y.
4
Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies.基于探针的邻近分析(ProPPr)揭示了tau蛋白病之间磷酸化tau相关蛋白质组的异同。
Mol Neurodegener. 2025 Mar 13;20(1):32. doi: 10.1186/s13024-025-00817-0.
5
Endosomal traffic disorders: a driving force behind neurodegenerative diseases.内体运输紊乱:神经退行性疾病背后的驱动力
Transl Neurodegener. 2024 Dec 24;13(1):66. doi: 10.1186/s40035-024-00460-7.
6
Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life span.与年龄相关的多巴胺神经元退化的自然变异与谷胱甘肽有关,并与寿命有关。
Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2403450121. doi: 10.1073/pnas.2403450121. Epub 2024 Oct 10.
7
VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress.VPS35 或 retromer 作为神经退行性疾病的潜在靶点:进展的障碍。
Expert Opin Ther Targets. 2024 Aug;28(8):701-712. doi: 10.1080/14728222.2024.2392700. Epub 2024 Aug 22.
8
Neurons Specialize in Presynaptic Autophagy: A Perspective to Ameliorate Neurodegeneration.神经元在突触前自噬方面具有特异性:改善神经退行性变的一个视角。
Mol Neurobiol. 2025 Feb;62(2):2626-2640. doi: 10.1007/s12035-024-04399-8. Epub 2024 Aug 14.
9
Aging, Parkinson's Disease, and Models: What Are the Challenges?衰老、帕金森病与模型:面临哪些挑战?
Aging Biol. 2023;1. doi: 10.59368/agingbio.20230010. Epub 2023 Jul 28.
10
Retromer-mediated recruitment of the WASH complex involves discrete interactions between VPS35, VPS29, and FAM21.Retromer 介导的 WASH 复合物的募集涉及 VPS35、VPS29 和 FAM21 之间的离散相互作用。
Protein Sci. 2024 May;33(5):e4980. doi: 10.1002/pro.4980.
帕金森病 VPS35[D620N]突变增强了小鼠和人类中 LRRK2 介导的 Rab 蛋白磷酸化。
Biochem J. 2018 Jun 6;475(11):1861-1883. doi: 10.1042/BCJ20180248.
4
Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.通过 PMCA 检测甲醛固定 MSA 患者组织中的 Alpha 突触核蛋白的种子活性。
Mol Neurobiol. 2018 Nov;55(11):8728-8737. doi: 10.1007/s12035-018-1007-y. Epub 2018 Mar 27.
5
G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain.LRRK2 G2019S 增强了小鼠大脑中 tau 的神经元传递。
Hum Mol Genet. 2018 Jan 1;27(1):120-134. doi: 10.1093/hmg/ddx389.
6
Aging Does Not Affect Axon Initial Segment Structure and Somatic Localization of Tau Protein in Hippocampal Neurons of Fischer 344 Rats.衰老并不影响费希尔 344 大鼠海马神经元轴突起始段结构和 tau 蛋白的体细胞定位。
eNeuro. 2017 Jul 21;4(4). doi: 10.1523/ENEURO.0043-17.2017. eCollection 2017 Jul-Aug.
7
VPS35, the Retromer Complex and Parkinson's Disease.VPS35、逆转录酶复合物与帕金森病
J Parkinsons Dis. 2017;7(2):219-233. doi: 10.3233/JPD-161020.
8
Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.富含亮氨酸重复激酶2(LRRK2)依赖性神经退行性变的机制:酶活性和蛋白质聚集的作用
Biochem Soc Trans. 2017 Feb 8;45(1):163-172. doi: 10.1042/BST20160264.
9
Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.纯合Vps35 D620N基因敲入小鼠纹状体多巴胺释放受损。
Hum Mol Genet. 2016 Oct 15;25(20):4507-4517. doi: 10.1093/hmg/ddw279.
10
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.帕金森病的遗传学:孟德尔遗传与非孟德尔遗传
J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):59-74. doi: 10.1111/jnc.13593. Epub 2016 Apr 18.